GL1X · GenesisL1 explorer

Research workbench

Enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the active R-enantiomer BMS270394.

Analyse Enantiomer discrimination illustrated by crystal structures of the human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1EXA
Type
protein
Length
236 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor gamma-2
UniProt
P22932
Ligands
394, LMU
Pockets
4 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 69% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor gamma-2protein23669% helix, 4% strandP22932

Ligands and binding sites

  • 394 · R-3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid · ligand · chains A
  • LMU · Dodecyl-alpha-D-maltoside · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12200.820.9433394
21200.500.8019empty
3820.410.7814empty
4860.330.7413empty

Compared structures

  • 1EXA · Enantiomer discrimination illustrated by crystal structures of the human retinoic acid… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.